[18F]LU13

N/A

Report date: 2022/07/14 16:07:22
NME

Base Information

Drug Name[18F]LU13
Drug Alias Name[18F]LU-13
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor modulators
TargetsCannabinoid CB2 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesHelmholtz-Zentrum Dresden-Rossendorf
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A